77 In addition, following potential benefits in metabolic syndrome and trials demonstrating improved liver fibrosis and fat deposition in the general population, a single-centre retrospective study of 29 liver transplant recipients found GLP-1RAs were associated with weight loss and improved glycemic control
Metab Brain Dis 40 , 127 (2025)
The injectable nature of GLP-1 RAs presents both challenges and opportunities for clinics: Challenges: Patient anxiety about self-injection, training requirements, cost of devices Opportunities: Regular contact with healthcare providers, controlled dispensing, ability to monitor adherence Administration Methods: Glutathione Unlike GLP-1 receptor agonists, glutathione can be administered through multiple routes, each with distinct advantages and considerations: 1
Different mechanisms, complementary benefits
[2] [1] However, several factors may explain why some patients might experience yeast infections whilst taking this medication